A new digital health tool for the telemonitoring of patients with scleroderma during iloprost administration: a feasibility and acceptability study.
Faggioli P, Zaccara E, Castelnovo L, Bompane D, Tamburello A, Lurati A, Laria A, Gangemi D, Giani M, Gnani D, Di Giorgi M, Iura K, Grandelis F, Piazza R, Piana T, Zizzo G, Mazzone A.
Faggioli P, et al. Among authors: di giorgi m.
Eur Rev Med Pharmacol Sci. 2023 Jan;27(2):799-804. doi: 10.26355/eurrev_202301_31081.
Eur Rev Med Pharmacol Sci. 2023.
PMID: 36734722
Free article.